Co-director of the Centre for Precision Medicine and Healthcare Research Centre at Tsinghua-Berkley Shenzhen Institute
Is the recipient of the Chinese Government Friendship Award, the highest honor given to foreigners from the People’s Republic of China
Has authored over 180 publications and is an international authority on molecular mechanisms of hormone action with a h-index of 55
Founding scientist of Perseis Therapeutics Ltd
He is also a founding shareholder in Wuhan Long Ke Ltd and Sinotar Therapeutics Ltd, two new entities focused on development of therapeutics to novel cancer target molecules.
Reviewer of more than 50 academic journals with more than 15 local and international granting agencies
Med.Sci. and M.B.B.S from University of Queensland, Australia